Document is current

Article History

Received: 10 October 2025

Accepted: 2 January 2026

First Online: 10 January 2026

Declarations

:

: Ethical approval from an institutional review board was not required, as this is a single case report with all patient identifiers removed from the text and images. A clinical trial registration number is not applicable.

: Nora Drick has received lecturing and consulting fees Glaxo-Smith-Klein, Sanofi and AstraZeneca.Till Kaireit has received lecturing fees from Siemens Healthineers, all unrelated to the present work.Jannik Ruwisch: has received lecturing and consulting fees from Boehringer Ingelheim and AstraZeneca.Sven Schallhorn has nothing to declare.Johann Bauersachs received honoraria for lectures/consulting from Novartis, Abbott, Bayer, Pfizer, Boehringer Ingelheim, AstraZeneca, Cardior, CVRx, BMS, Amgen, Edwards, Roche, Zoll not related to this article; and research support for the department from Zoll, CVRx, Abiomed, Norgine, Roche, all unrelated to the present work.Heiko Schenk has received fees for lectures or consultations from AstraZeneca, Glaxo-Smith-Kline, and Otsuka, all unrelated to the present work.Marius M. Hoeper has received fees for lectures or consultations from Acceleron, Actelion, AOP Health, Bayer, Ferrer, GossamerBio, Janssen, Keros, and MSD, all unrelated to the present work.Torsten Witte has received lecturing and consulting fees from Glaxo-Smith-Kline and from AstraZeneca.Benjamin Seeliger has received lecturing and consulting fees from Boehringer Ingelheim, Glaxo-Smith-Klein and AstraZeneca.